Displacement of Drugs from Human Serum Albumin: From Molecular Interactions to Clinical Significance

Author(s): Hrvoje Rimac, Željko Debeljak*, Mirza Bojić, Larisa Miller.

Journal Name: Current Medicinal Chemistry

Volume 24 , Issue 18 , 2017

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


Background: Human serum albumin (HSA) is the most abundant protein in human serum. It has numerous functions, one of which is transport of small hydrophobic molecules, including drugs, toxins, nutrients, hormones and metabolites. HSA has the ability to interact with a wide variety of structurally different compounds. This promiscuous, nonspecific affinity can lead to sudden changes in concentrations caused by displacement, when two or more compounds compete for binding to the same molecular site.

Objective: It is important to consider drug combinations and their binding to HSA when defining dosing regimens, as this can directly influence drug’s free, active concentration in blood.

Conclusion: In present paper we review drug interactions with potential for displacement from HSA, situations in which they are likely to occur and their clinical significance. We also offer guidelines in designing drugs with decreased binding to HSA.

Keywords: Human serum albumin, drug displacement, pharmacokinetic interactions, free concentration, drug design, Sudlow’s site I, Sudlow’s site II.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Page: [1930 - 1947]
Pages: 18
DOI: 10.2174/0929867324666170202152134
Price: $58

Article Metrics

PDF: 75
PRC: 1